EUVIMEDEUVIMED entdecken
Open Access

Oridonin ameliorates ulcerative colitis by regulating the PI3K/AKT/mTOR signaling pathway to activate autophagy

Zhongxing Miao, Baohong Liu, Xingzhi Zhou, Mengru Lu, Ni Jia, Huamin Zhang, Ying Qi, Xiaoyu Tan, Qinggao Zhang

International Journal of Molecular Medicine · 2026

DOI: 10.3892/ijmm.2026.5894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Medicine, 2026. Verfasst von Zhongxing Miao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Biology Key Laboratory, Yanbian University, Yanji, Jilin 133002, P.R. China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Diterpenes, Kaurane. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study aimed to investigate the therapeutic effects and underlying mechanism of oridonin (ORI) in ulcerative colitis (UC) using the lipopolysaccharide (LPS)‑induced macrophage inflammatory model in vitro and the dextran sulfate sodium (DSS)‑induced mouse UC model in vivo. Cell Counting Kit‑8 assay was used to determine the appropriate drug concentrations for the in vitro experiments. Western blotting and reverse transcription‑quantitative polymerase chain reaction were performed to evaluate the expression levels of proteins and mRNAs related to signaling pathways, autophagy and inflammatory cytokines. The autophagy inhibitor 3‑methyladenine was applied to verify the role of the PI3K/AKT/mTOR pathway. In vivo, the disease activity index (DAI) was recorded and colon tissue damage was assessed by hematoxylin and eosin staining. Serum inflammatory cytokines were measured using an enzyme‑linked immunosorbent assay. Network pharmacology based on GeneCards and Traditional Chinese Medicine Systems Pharmacology databases, along with Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis, predicted involvement of the PI3K/AKT/mTOR pathway in the pathogenesis of UC, which was further validated by the immunohistochemistry, immunofluorescence and western blotting of colon tissues. The results indicated that ORI significantly reduced the expression of pro‑inflammatory cytokines and increased the anti‑inflammatory cytokine interleukin‑10 in LPS‑stimulated macrophages. In DSS‑induced colitis mice, ORI treatment alleviated body weight loss, decreased DAI scores, improved colon shortening and upregulated the expression of intestinal tight junction proteins. Mechanistically, ORI inhibited the PI3K/AKT/mTOR pathway and altered autophagy‑related molecular markers, as evidenced by increased levels of autophagy‑related (ATG)13, beclin‑1, ATG12, ATG7 and ATG5 as well as decreased expression of p62. In conclusion, ORI alleviates inflammatory responses in vitro and mitigates UC‑related pathological changes in vivo, which may be associated with suppression of the PI3K/AKT/mTOR pathway and modulation of autophagy‑associated protein markers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktDiterpenes, KauraneAutophagySignal TransductionPhosphatidylinositol 3-KinasesAnimalsMiceMaleDextran SulfateCytokinesDisease Models, AnimalRAW 264.7 CellsMice, Inbred C57BLLipopolysaccharides

Stichwörter der Autor:innen

PI3K/AKT/mTORautophagyinflammationoridoninulcerative colitis

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktoridoninDiterpenes, KauranePhosphatidylinositol 3-KinasesDextran SulfateCytokinesmTOR protein, mouseLipopolysaccharides

Autor:innen und Institutionen

  • Immunology Biology Key Laboratory, Yanbian University, Yanji, Jilin 133002, P.R. China.
  • Department of Medical Supervision, Tianjin Binhai New Area Center for Disease Control and Prevention, Tianjin 300451, P.R. China.
  • Health Medicine Translational Research Center, School of Basic Medical Sciences, Dalian University, Dalian, Liaoning 116622, P.R. China.
  • Department of Central Laboratory, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, P.R. China.
  • Department of Clinical Laboratory, Xin Hua Hospital Affiliated to Dalian University, Dalian, Liaoning 116021, P.R. China.

Zitieren

APA

Miao, Z., Liu, B., Zhou, X., Lu, M., Jia, N., Zhang, H., Qi, Y., Tan, X., & Zhang, Q. (2026). Oridonin ameliorates ulcerative colitis by regulating the PI3K/AKT/mTOR signaling pathway to activate autophagy. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2026.5894

Vancouver

Miao Z, Liu B, Zhou X, Lu M, Jia N, Zhang H, et al. Oridonin ameliorates ulcerative colitis by regulating the PI3K/AKT/mTOR signaling pathway to activate autophagy. International Journal of Molecular Medicine. 2026. doi:10.3892/ijmm.2026.5894

BibTeX
@article{Miao2026,
  author = {Miao, Zhongxing and Liu, Baohong and Zhou, Xingzhi and Lu, Mengru and Jia, Ni and Zhang, Huamin and Qi, Ying and Tan, Xiaoyu and Zhang, Qinggao},
  title = {Oridonin ameliorates ulcerative colitis by regulating the PI3K/AKT/mTOR signaling pathway to activate autophagy},
  journal = {International Journal of Molecular Medicine},
  year = {2026},
  doi = {10.3892/ijmm.2026.5894}
}
Kostenlos starten →